MedTrace Logo

Safety and Performance Study of the CardioGard Cannula

NCT01554709 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2014-09-25

No results posted yet for this study

Summary

The objective of the study is to collect additional information related to the safety and performance of the CardioGard Cannula during bypass procedures.

Conditions

  • Aortic Valve Replacement

Interventions

DEVICE

Aortic Cannulas (CardioGard)

Comparison of aortic cannulas during by pass surgery

Sponsors & Collaborators

  • CardioGard Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Gil Bolotin, Dr. · Rambam Health Care Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2014-05-31

Countries

  • Germany
  • Israel
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01554709 on ClinicalTrials.gov